Clinical Trials in Salt Lake City

Showing 10881-10900 of 16,694 trials

Contact Lenses With New UV-blocker Manufactured With Different Techniques

NCT03475875

This study is a randomized, 4-visit, double-masked, 2x3 bilateral crossover, dispensing trial. The study lenses will be worn as daily wear (DW) for a period of two weeks each with one of the study lenses being worn twice. Each study lens is expected to be worn at least five (5) days per week for at least six (6) hours per day worn. There will be no washout period between study lenses.

Correction of Refraction ErrorAttenuation of Bright Light

Johnson & Johnson Vision Care, Inc.92 participantsStarted Feb 2018

Foster City, California, United States • Jacksonville, Florida, United States • Pickens, South Carolina, United States +2 more locations

COMPLETEDPhase 1< 1 mile

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

NCT02036645

The purpose of this study is to assess the safety, drug levels and effects on the body of 1 or 3 injections of MEDI1814, in people with mild to moderate Alzhiemer's Disease or healthy elderly people.

Mild-Moderate Alzheimer's DiseaseHealthy Elderly

AstraZeneca77 participantsStarted Feb 2014

Glendale, California, United States • Long Beach, California, United States • Panorama City, California, United States +7 more locations

Contact Lenses With New UV-blocker Manufactured With Different Techniques

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

Find Trials by Condition in Salt Lake City

The Plecanatide Chronic Idiopathic Constipation (CIC) Study

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

12-Week Study of Plecanatide for CIC (The National CIC3 Study)

SILVER-AMI: Outcomes in Older Persons With Heart Attacks

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Randomized Safety Study of CVT-301 Compared to an Observational Control Group

BKM120 as Second-line Therapy for Advanced Endometrial Cancer

International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma

Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome

Trending of Respiratory Rate Using the Nellcor™ Bedside Respiratory Patient Monitoring System

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)